Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...

Chronic urticaria occurs in about 0.1% of the population (Greaves, 2000). Patients previously classified as having chronic idiopathic or "ordinary" urticaria are now divided into two groups: 40% ...

The company paused testing of one candidate acquired in its April deal for Escient and scrapped another in a blow to its ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

If you have chronic hives, which means they linger for at least six weeks, you may be prescribed medications, including anti-inflammatory drugs, drugs that suppress the immune system, and drugs ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

In a case reported by Baptist and Baldwin (2004), a 33-year-old woman with a history of endometriosis presented with complaints of chronic urticaria ... was diagnosed with autoimmune progesterone ...

but can now point to a win for rilzabrutinib in chronic spontaneous urticaria (CSU). In a phase 2 trial, rilzabrutinib has been shown to rapidly reduce itch severity and significantly improve ...

Opens in a new tab or window BOSTON -- Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) whose symptoms were uncontrolled ...